Erkang Tian

机构：Sichuan University, West China Medical Center of Sichuan University, Henan Tianguan Group (China), West China Hospital of Sichuan University, Stomatology Hospital, State Key Laboratory of Oral Diseases · ORCID：0009-0006-4685-1005

发表论文 28 篇 · 总被引 305 次 · h-index 8

代表论文

• Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective (2022 · Frontiers in Pharmacology · 被引 71)
• Multifunctional Metal–Phenolic Composites Promote Efficient Periodontitis Treatment via Antibacterial and Osteogenic Properties (2024 · ACS Applied Materials & Interfaces · 被引 39)
• Gut microbiota and its roles in the pathogenesis and therapy of endocrine system diseases (2022 · Microbiological Research · 被引 34)
• Comprehensive review on neprilysin (NEP) inhibitors: design, structure-activity relationships, and clinical applications (2024 · Frontiers in Pharmacology · 被引 19)
• RIPK2 inhibitors for disease therapy: Current status and perspectives (2023 · European Journal of Medicinal Chemistry · 被引 18)
• ADAM17 as a promising therapeutic target: from structural basis to inhibitor discovery in human diseases (2025 · Frontiers in Pharmacology · 被引 10)